Patents by Inventor Anna Gosiewska

Anna Gosiewska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170360941
    Abstract: A composition comprising: a benefit agent; at least one polymer including a polycaprolactone polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent is disclosed.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 21, 2017
    Inventors: Ying Sun, Anna Gosiewska, Dennis D. Jamiolkowski, Jeffrey M. Wu
  • Publication number: 20170326183
    Abstract: Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 16, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Sanjay Mistry, Anthony J. Kihm, Ian R. Harris, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Patent number: 9782485
    Abstract: A composition comprising: a benefit agent; at least one polymer including a polycaprolactone polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent is disclosed.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: October 10, 2017
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Ying Sun, Anna Gosiewska, Dennis D. Jamiolkowski, Jeffrey M. Wu
  • Publication number: 20170239299
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Application
    Filed: February 27, 2017
    Publication date: August 24, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian Ross Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Patent number: 9717763
    Abstract: Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
    Type: Grant
    Filed: September 5, 2013
    Date of Patent: August 1, 2017
    Assignee: DEPUY SYNTHES PRODUCTS, INC.
    Inventors: Sanjay Mistry, Anthony J. Kihm, Ian R. Harris, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20170202212
    Abstract: This invention provides for compositions for cryopreservation of human umbilical cord tissue-derived cells. The cryopreservation compositions may comprise: (a) amino acids; (b) vitamins; (c) inorganic salts; and (d) DMSO, sucrose, mannitol, and lactobionic acid. The invention also provides for kits comprising the composition and human umbilical cord tissue-derived cells and methods of cryopreserving the cells, which utilize the compositions.
    Type: Application
    Filed: January 6, 2017
    Publication date: July 20, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Anna Gosiewska, Anthony J. Kihm
  • Publication number: 20170166863
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 15, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian Ross Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20170166864
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 15, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian Ross Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20170143770
    Abstract: Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.
    Type: Application
    Filed: November 28, 2016
    Publication date: May 25, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Laura J. Brown, Alexander M. Harmon, Anna Gosiewska
  • Patent number: 9650611
    Abstract: An isolated mammalian internal mammary artery-derived cell is disclosed. Furthermore, methods of isolating the mammalian internal mammary artery-derived cell are disclosed. The cell is useful in tissue engineering technologies, specifically in vascular tissue engineering.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: May 16, 2017
    Assignee: DEPUY SYNTHES PRODUCTS, LLC
    Inventors: David C. Colter, Charito Buensuceso, Christian C. Kazanecki, Anna Gosiewska
  • Patent number: 9592258
    Abstract: Methods, pharmaceutical compositions and kits for regenerating or repairing neural tissue, decreasing apoptosis and improving neurological function following injury using human umbilical cord tissue-derived cells are disclosed.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: March 14, 2017
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Agnieszka Seyda, Anna Gosiewska
  • Publication number: 20170065718
    Abstract: A composition comprising: a benefit agent; at least one polymer including a poly(monostearoyl glycerol-co-succinate) polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent are disclosed.
    Type: Application
    Filed: November 17, 2016
    Publication date: March 9, 2017
    Inventors: Ying Sun, Anna Gosiewska, Aruna Nathan, Jeffrey M. Wu
  • Publication number: 20170065745
    Abstract: Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells and optionally a hydrogel. In some embodiments, administering the cells promotes repair and regeneration of degenerated IVD tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Application
    Filed: November 21, 2016
    Publication date: March 9, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Laura J. Brown, Anna Gosiewska, Anthony J. Kihm, Brian C. Kramer
  • Publication number: 20170065644
    Abstract: Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells. In some embodiments, administering the cells promotes repair and regeneration of degenerated IVD tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Application
    Filed: November 21, 2016
    Publication date: March 9, 2017
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Laura J. Brown, Anna Gosiewska, Anthony J. Kihm, Brian C. Kramer
  • Patent number: 9579351
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: February 28, 2017
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian Ross Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20170049931
    Abstract: A biocompatible tissue repair implant or scaffold device is provided for use in repairing a variety of tissue injuries, particularly injuries to cartilage, ligaments, tendons, and nerves. The repair procedures may be conducted with implants that contain a biological component that assists in healing or tissue repair. The biocompatible tissue repair implants include a biocompatible scaffold and particles of living tissue, such that the tissue and the scaffold become associated. The particles of living tissue contain one or more viable cells that can migrate from the tissue and populate the scaffold.
    Type: Application
    Filed: October 31, 2016
    Publication date: February 23, 2017
    Inventors: Francois Binette, Julia Hwang, Sridevi Dhanaraj, Anna Gosiewska
  • Publication number: 20170049681
    Abstract: A composition comprising: a benefit agent; at least one polymer including a polycaprolactone polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent is disclosed.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Inventors: Ying Sun, Anna Gosiewska, Dennis D. Jamiolkowski, Jeffrey M. Wu
  • Patent number: 9572840
    Abstract: Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of neural tissue using the postpartum-derived cells are also disclosed.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: February 21, 2017
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Darin J. Messina, Alexander M. Harmon, Ian R. Harris, Anthony J. Kihm, Sanjay Mistry, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20160375062
    Abstract: Isolated or purified mammalian kidney-derived cell populations from mammalian kidney tissue are provided. Methods are provided for the isolation and purification of the mammalian kidney-derived cell population. Methods for treating kidney disease are provided by administration of the isolated or purified mammalian kidney-derived cell population to a mammalian subject.
    Type: Application
    Filed: August 17, 2016
    Publication date: December 29, 2016
    Applicant: DePuy Synthes Products, Inc.
    Inventors: David C. Colter, Agnieszka Seyda, Charito S. Buensuceso, Anna Gosiewska
  • Patent number: 9522189
    Abstract: A composition comprising: a benefit agent; at least one polymer including a poly(monostearoyl glycerol-co-succinate) polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent are disclosed.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: December 20, 2016
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Ying Sun, Anna Gosiewska, Aruna Nathan, Jeffrey M. Wu